Meanwhile, our experimental results demonstrate that when SPI1 is highly expressed or ACSL4 is lowly expressed, the combination of ferroptosis inducers with EZH2 inhibitors can promote ferroptosis in ccRCC. This evidence concerns the gene SPI1 and nonpapillary renal cell carcinoma.